Targeted degradation of hexokinase 2 by a novel engineered bispecific chimeric liposome-based Nano-PROTACs for enhancing tumor chemotherapy.
第一作者:
Linlin,Gong
第一单位:
Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, Guangdong, 518057, China.
作者:
医学主题词
脂质体(Liposomes);动物(Animals);己糖激酶(Hexokinase);人类(Humans);细胞系, 肿瘤(Cell Line, Tumor);多柔比星(Doxorubicin);小鼠(Mice);女(雌)性(Female);小鼠, 近交BALB C(Mice, Inbred BALB C);抗肿瘤药(Antineoplastic Agents);肿瘤(Neoplasms)
DOI
10.1016/j.biomaterials.2025.123651
PMID
40911960
发布时间
2025-11-03
- 浏览0
Biomaterials
123651页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



